Upload
across-health
View
6.840
Download
0
Embed Size (px)
Citation preview
Fonny Schenck, CEO Sander Speleman, Sr Consultant Patient Engagement
View recorded webinar: http://bit.ly/1QcylHb
Across Health Webinar
Health Outcomes as #1 objective: Connected Health & Disruptive innovation in pharma
© Across Health Webinar 1
Some numbers 2015
over 60 consultants
Physical presence in 10 markets
Over 300 projects (40% in
customer insight & strategy)
Channel affinity of 8000 HCPs
(Navigator)
25+% CAGR since 2007
© Across Health Webinar 3
What we will cover today
• Healthcare in the digital age
• Opportunities & threats for pharma
• What did we learn during the Healthcare Disruption Tour?
• Q&A
New patient – physician relationship
© Across Health Webinar 9
“a new emerging partnership in medicine without the historic information asymmetry. Without the high priests, paternalism, and Doctor Knows Best attitude.”
–Eric Topol, MD
Acute Diagnostics, When and Where They are Needed
© Across Health Webinar 12
More than a million people are searching on Google for information on ear infection at 4:30 a.m. every morning
Ryan Olohan, Industry Director, Healthcare. Google Inc. October 2015
© Across Health Webinar 22
With the exception of physical activity, more consumers are currently tracking key health factors on paper or in their heads than with mobile applications.
Finding the right pace
© Across Health Webinar 25
It ought to be remembered that there is nothing more difficult to take in hand, more perilous to conduct, or more uncertain in its success, than to take the lead in the introduction of a new order of things. Because the innovator has for enemies all those who have done well under the old conditions, and lukewarm defenders in those who may do well under the new. This coolness arises partly from fear of the opponents, who have the laws on their side, and partly from the incredulity of men, who do not readily believe in new things until they have had a long experience of them. -- Niccolo Macchiavelli
Central healthcare innovation teams are becoming more established, but the impact is perceived low
© Across Health 30
26%
54%
20%
Yes, just being created Yes, but the impact is low Yes, and it is highly effective
Don’t know / not sure
11%
No 35%
Yes 54%
N = 260 Global scope
Do you have a central Healthcare Innovation team?
Early days for mhealth tactics
© Across Health 31
78%
75%
61%
60%
55%
45%
44%
42%
36%
33%
31%
29%
23%
21%
21%
21%
19%
15%
13%
11%
9%
7%
6%
6%
4%
12%
17%
29%
12%
26%
34%
41%
29%
39%
44%
27%
26%
53%
41%
37%
35%
36%
39%
13%
29%
35%
16%
21%
24%
23%
6%
4%
7%
18%
13%
13%
10%
19%
16%
17%
30%
34%
19%
26%
38%
35%
38%
37%
43%
45%
43%
55%
54%
51%
52%
4%
4%
4%
10%
6%
8%
4%
10%
9%
6%
12%
11%
4%
12%
4%
9%
7%
10%
30%
15%
12%
22%
19%
19%
20%
Tablet eDetailing
Pharma-owned website*
Email marketing
Direct marketing
Web Banners
Online MedEd
Web conference
SEO
HCP self-service portal
Mobile marketing
SEA
Outbound Call Center
Integrated cross-channel campaigns
Patient compliance/adherence
Social media marketing
Virtual eDetailing
Social media monitoring
eRep
e-sampling
Marketing automation software
eMSL
ePrescribing advertising
personal health records advertising
Quantified self / self-tracking devices
Remote patient monitoring
Standard practice Pilot planned or ongoing Never Do not know / not applicable
*Company, product, or disease website. **electronic or personal health record.
What is the Healthcare Disruption Tour?
• A unique 5-day tour to the heart of the action in healthcare disruption
• 3 days in Silicon Valley
• 2 days in San Diego
• 13 company visits
• Big technology players
• Traditional healthcare companies
• Venture capital companies
• Tech start-ups
• Research institutions
• Target audience:
• Pharma & healthcare executives
• Healthcare entrepreneurs
© Across Health Webinar 37
Our objectives
• Meet the creative thinkers and doers who are reshaping healthcare
• Be inspired by the spirit of the Valley to participate in the disruption of healthcare
• Learn about philosophies and business models
• Identify business opportunities (partnerships, investment possibilities, …)
© Across Health Webinar 39
NPS = 71!
An amazing experience, every minute was worth it! This Tour was an eye opener, there is a before Tour and an
after Tour life!
It even surpassed my expectations and reasons why I was joining the tour.
It was a great and enriching experience all round. The companies, your support, the locations as well the other
participants. Thoroughly enjoyed it and taking a lot of insights back to my company.
Great how you managed to get us in front of top thinkers/actors!
What did we learn from the Tour?
© Across Health Webinar 43
• Healthcare is more difficult to disrupt than other industries
• The size of the prize is huge, but regulations & defenders of the status-quo have hampered progress – so far
• “The second coming” of digital health/medicine is underway
• Pharma can play a key role in the new ecosystem if they are willing to embrace the change
• The question is not IF healthcare disruption is coming. The question is WHEN.
• To disrupt or be disrupted, that’s the question
Check our blog on www.healthcaredisruption.com!
What’s next? Be part of the healthcare disruption!
© Across Health Webinar 44
HEALTHCARE DISRUPTION TOUR
HEALTHCARE DISRUPTION E-CADEMY
HEALTHCARE DISRUPTION COMMUNITY
Nothing better than a real life F2F
experience
IN 2016
1 Tour to the East-Coast
1 Tour to the West-Coast
Continuous and remote learning
from the disruptors
START Q2 2016
Subscription per 6 months
1 online session every 3 weeks
We believe in healthcare
disruption as a collective effort
START Q2 2016 Connect with peers
in our business community and move forward
Register your area(s) of interest on www.healthcaredisruption.com
© Across Health Webinar 45
Register for the future in healthcare
www.healthcaredisruption.com/signin